Clinical Trials in Psychopharmacology: A Better Brain, 2nd ed
J Clin Psychiatry 2011;72(4):571 [book review]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
From our regular book review column.
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
This superb volume is the second edition of a multiauthored book designed to review published clinical trials of psychotropic medications and the implications of the research results. A great wealth of information is contained in these well-edited and well-organized pages, but the reader should take heed: this is not a book for a beginning clinician, and it most certainly is not a “how-to” handbook for prescribing psychiatric medications.
What it contains, however, are chapters that helpfully review and synthesize the research data on medications for mood, anxiety, addictive, and impulsive disorders; review the complex and sometimes contradictory data on attention-deficit/hyperactivity disorder, autism spectrum disorders, and antipsychotic drugs for schizophrenia; and discuss special issues for the treatment of women patients in clinical trials.